GIANT BIOGENE (02367) Plans Share Buyback Under Repurchase Authorization

Stock News12-02

GIANT BIOGENE (02367) announced its intention to exercise the general mandate for share repurchases granted by shareholders. The board disclosed plans to utilize the authority approved during the company's annual general meeting on June 13, 2025, to buy back shares.

Under the repurchase authorization, the company is permitted to acquire up to 104 million shares, representing 10% of the total issued shares (excluding treasury shares) as of the AGM resolution date. This authorization will expire upon the earliest occurrence of: (i) the conclusion of the next annual general meeting, (ii) the deadline for holding the next AGM as required by the company's articles or applicable laws, or (iii) the date when shareholders revoke or amend the authorization through an ordinary resolution.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1175059183?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 12:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175059183","market":"nz","top_or_hot":-1,"title":"GIANT BIOGENE (02367) Plans Share Buyback Under Repurchase Authorization","media":"Stock News","content":"<p>GIANT BIOGENE (02367) announced its intention to exercise the general mandate for share repurchases granted by shareholders. The board disclosed plans to utilize the authority approved during the company's annual general meeting on June 13, 2025, to buy back shares.</p>\n<p>Under the repurchase authorization, the company is permitted to acquire up to 104 million shares, representing 10% of the total issued shares (excluding treasury shares) as of the AGM resolution date. This authorization will expire upon the earliest occurrence of: (i) the conclusion of the next annual general meeting, (ii) the deadline for holding the next AGM as required by the company's articles or applicable laws, or (iii) the date when shareholders revoke or amend the authorization through an ordinary resolution.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GIANT BIOGENE (02367) Plans Share Buyback Under Repurchase Authorization</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGIANT BIOGENE (02367) Plans Share Buyback Under Repurchase Authorization\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-02 12:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GIANT BIOGENE (02367) announced its intention to exercise the general mandate for share repurchases granted by shareholders. The board disclosed plans to utilize the authority approved during the company's annual general meeting on June 13, 2025, to buy back shares.</p>\n<p>Under the repurchase authorization, the company is permitted to acquire up to 104 million shares, representing 10% of the total issued shares (excluding treasury shares) as of the AGM resolution date. This authorization will expire upon the earliest occurrence of: (i) the conclusion of the next annual general meeting, (ii) the deadline for holding the next AGM as required by the company's articles or applicable laws, or (iii) the date when shareholders revoke or amend the authorization through an ordinary resolution.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02367","symbol_name":"巨子生物","start_time":0,"source_url":"","article_id":"1175059183","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175059183","pubTimestamp":1764650050,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"GIANT BIOGENE (02367) announced its intention to exercise the general mandate for share repurchases granted by shareholders. The board disclosed plans to utilize the authority approved during the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02367":"巨子生物","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD","BK1207":"个人用品"},"translate_title":"GIANT BIOGENE(02367)计划根据回购授权回购股份","themeId":"93fb2e47c9fd33d3ba859dde5032b51d","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"GIANT BIOGENE (02367) announced its intention to exercise the general mandate for share repurchases granted by shareholders. The board disclosed plans to utilize the authority approved during the company's annual general meeting on June 13, 2025, to buy back shares.\nUnder the repurchase authorization, the company is permitted to acquire up to 104 million shares, representing 10% of the total issued shares (excluding treasury shares) as of the AGM resolution date. This authorization will expire upon the earliest occurrence of: (i) the conclusion of the next annual general meeting, (ii) the deadline for holding the next AGM as required by the company's articles or applicable laws, or (iii) the date when shareholders revoke or amend the authorization through an ordinary resolution.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1175059183","isCrawlerRequest":true}